What Do Patients Experience Between Visits, and Why Does It Matter?
What Do Patients Experience Between Visits, and Why Does It Matter? Join this live webinar to learn more. Many therapies are approved on surrogate endpoints that often say little about which therapy is best for a patient’s needs. In nephrology, IgAN went from zero to six approved therapies in the last 5 years, each first…
